🔥🐔 BizChicken 🐔🔥

Companies Similar to Turnstone Biologics Corp.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

BioAtla, Inc.

BioAtla, Inc. logo
Market Cap: Low
Employees: Low

BA3011

Bio Atla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Their lead product candidate is BA3011, targeting various cancers.

Tags: antibody-based therapeutics, biopharmaceutical, cancer, clinical stage, solid tumor

Symbol: BCAB

Recent Price: $0.59

Industry: Biotechnology

CEO: Dr. Jay M. Short Ph.D.

Sector: Healthcare

Employees: 65

Address: 11085 Torreyana Road, San Diego, CA 92121

Phone: 858 558 0708

Last updated: 2024-12-31

Candel Therapeutics, Inc.

Candel Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

CAN-2409, CAN-3110

Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.

Tags: biopharmaceutical, cancer treatment, clinical trials, immunotherapies

Symbol: CADL

Recent Price: $7.95

Industry: Biotechnology

CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.

Sector: Healthcare

Employees: 42

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 617 916 5445

Last updated: 2024-12-31

Telomir Pharmaceuticals, Inc. Common Stock

Telomir Pharmaceuticals, Inc. Common Stock logo
Market Cap: Low
Employees: Lowest

TELOMIR-1

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.

Tags: TELOMIR-1, inflammatory conditions, pharmaceutical, stem cells, therapeutic treatment

Symbol: TELO

Recent Price: $4.64

Industry: Biotechnology

CEO: Mr. Erez Aminov

Sector: Healthcare

Employees: 1

Address: 855 N Wolfe Street, Baltimore, null 21205

Phone: (737)-289-0835

Last updated: 2024-12-31

Tyra Biosciences, Inc.

Tyra Biosciences, Inc. logo
Market Cap: Medium
Employees: Lowest

TYRA-300

Tyra Biosciences, Inc. is a preclinical-stage biopharmaceutical company focused on developing therapies to overcome tumor resistance and enhance outcomes for cancer patients. Its lead product candidate is TYRA-300, a selective inhibitor of FGFR3 for treating muscle invasive bladder cancer.

Tags: FGFR, biopharmaceutical, cancer therapy, preclinical, tumor resistance

Symbol: TYRA

Recent Price: $13.90

Industry: Biotechnology

CEO: Dr. Todd Harris Ph.D.

Sector: Healthcare

Employees: 49

Address: 2656 State Street, Carlsbad, CA 92008

Phone: 619 728 4760

Last updated: 2024-12-31

Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. logo
Market Cap: Low
Employees: Low

TN-201, TN-301, TN-401

Tenaya Therapeutics, Inc. is a biotechnology company that discovers, develops, and delivers therapies for heart disease using cellular regeneration, gene therapy, and precision medicine platforms.

Tags: biotechnology, gene therapy, heart disease, precision medicine, therapeutics

Symbol: TNYA

Recent Price: $1.45

Industry: Biotechnology

CEO: Mr. Faraz Ali M.B.A.

Sector: Healthcare

Employees: 140

Address: 171 Oyster Point Boulevard, South San Francisco, CA 94080

Phone: 650 825 6900

Last updated: 2024-12-31

Tourmaline Bio, Inc.

Tourmaline Bio, Inc. logo
Market Cap: Medium
Employees: Low

medicines for immune diseases

Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

Tags: ASCVD, TED, biotechnology, clinical development, immune diseases

Symbol: TRML

Recent Price: $20.08

Industry: Biotechnology

CEO: Dr. Sandeep C. Kulkarni M.D.

Sector: Healthcare

Employees: 70

Address: 27 West 24th Street, New York, NY 10010

Phone: 646-481-9832

Last updated: 2024-12-31

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

T-cell immunotherapy treatments

Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.

Tags: Autoimmune Diseases, Biotherapeutics, Cancer Treatment, Immunotherapy, T-Cell Therapy, Viral Diseases

Symbol: ATRA

Recent Price: $13.28

Industry: Biotechnology

CEO: Dr. Anhco Nguyen Ph.D.

Sector: Healthcare

Employees: 165

Address: 611 Gateway Boulevard, South San Francisco, CA 94080

Phone: 650 278 8930

Last updated: 2024-12-31

Gritstone bio, Inc.

Gritstone bio, Inc. logo
Market Cap: Lowest
Employees: Low

GRANITE

Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.

Tags: HIV, SARS-CoV-2, biotechnology, cancer treatment, immunotherapy, infectious diseases

Symbol: GRTS

Recent Price: $0.03

Industry: Biotechnology

CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.

Sector: Healthcare

Employees: 231

Address: 5959 Horton Street, EmeryVille, CA 94608

Phone: 510 871 6100

Last updated: 2024-12-31

Intensity Therapeutics, Inc.

Intensity Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

INT230-6

Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.

Tags: biotechnology, cancer treatment, clinical trials, collaboration, solid tumors

Symbol: INTS

Recent Price: $1.82

Industry: Biotechnology

CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.

Sector: Healthcare

Employees: 5

Address: 61 Wilton Road, Westport, CT 06880

Phone: 203 221 7381

Leadership

  • Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
  • Joseph Talamo, CPA, Chief Financial Officer
  • James M. Ahlers, Executive Vice President
  • Brian Schwartz, MD, Executive VP, Clinical Development
  • John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
  • Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
  • Doranne Frano, Regulatory Affairs and Quality Control
  • Daniel J. Donovan, Board Member and Chief Executive Officer
  • Tom Dubin, Board Member
  • Mark A. Goldberg, MD, Board Member
  • Emer Leahy, Ph.D., Board Member

Last updated: 2024-12-31

Kura Oncology, Inc.

Kura Oncology, Inc. logo
Market Cap: High
Employees: Low

ziftomenib and tipifarnib

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.

Tags: biopharmaceutical, cancer treatment, clinical trials, hematologic, leukemia, small molecule, solid tumors

Symbol: KURA

Recent Price: $8.51

Industry: Biotechnology

CEO: Dr. Troy Edward Wilson J.D., Ph.D.

Sector: Healthcare

Employees: 142

Address: 12730 High Bluff Drive, San Diego, CA 92130

Phone: 858 500 8800

Last updated: 2024-12-31

Sana Biotechnology, Inc.

Sana Biotechnology, Inc. logo
Market Cap: Medium
Employees: Medium

N/A

Sana Biotechnology, Inc. focuses on utilizing engineered cells as medicines, developing cell engineering platforms for various therapeutic areas including oncology, diabetes, and genetic disorders.

Tags: biotechnology, cell engineering, genetic disorders, medicine, oncology

Symbol: SANA

Recent Price: $1.61

Industry: Biotechnology

CEO: Dr. Steven D. Harr M.D.

Sector: Healthcare

Employees: 328

Address: 188 East Blaine Street, Seattle, WA 98102

Phone: 206 701 7914

Last updated: 2024-12-31

TRACON Pharmaceuticals, Inc.

TRACON Pharmaceuticals, Inc. logo
Market Cap: Lowest
Employees: Lowest

therapeutics for cancer

TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.

Tags: TJ004309, TRC102, YH001, biopharmaceutical, cancer therapeutics, clinical trials, envafolimab

Symbol: TCON

Recent Price: $0.03

Industry: Biotechnology

CEO: Mr. Craig R. Jalbert CIRA

Sector: Healthcare

Employees: 17

Address: 4350 La Jolla Village Drive, San Diego, CA 92122

Phone: 858 550 0780

Last updated: 2024-12-31

TG Therapeutics, Inc.

TG Therapeutics, Inc. logo
Market Cap: High
Employees: Low

Ublituximab, Umbralisib, Cosibelimab, TG-1701, TG-1801

TG Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on developing and commercializing novel treatments for B-cell malignancies and autoimmune diseases.

Tags: B-cell malignancies, BTK inhibitor, Cosibelimab, Ublituximab, Umbralisib, autoimmune diseases, biopharmaceutical

Symbol: TGTX

Recent Price: $31.45

Industry: Biotechnology

CEO: Mr. Michael S. Weiss Esq.

Sector: Healthcare

Employees: 264

Address: 2 Gansevoort Street, New York, NY 10014

Phone: 212 554 4484

Leadership

  • Michael S. Weiss, Chairman, President, and Chief Executive Officer
  • Sean A. Power, CPA, Chief Financial Officer
  • Adam Waldman, Chief Commercialization Officer

Last updated: 2024-12-31

Third Harmonic Bio, Inc.

Third Harmonic Bio, Inc. logo
Market Cap: Medium
Employees: Lowest

THB001

Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.

Tags: KIT inhibitor, allergic diseases, biopharmaceutical, chronic urticaria, clinical-stage, inflammatory diseases

Symbol: THRD

Recent Price: $10.38

Industry: Biotechnology

CEO: Ms. Natalie C. Holles

Sector: Healthcare

Employees: 42

Address: 300 Technology Square, Cambridge, MA 02139

Phone: 617-915-6680

Last updated: 2024-12-31

Talis Biomedical Corporation

Talis Biomedical Corporation logo
Market Cap: Lowest
Employees: Low

Talis One

Talis Biomedical Corporation operates as a molecular diagnostic company. It is developing the Talis One system to enhance point-of-care diagnostic testing for infectious diseases, offering tests for COVID-19 and other respiratory infections.

Tags: COVID-19, Talis One, infectious diseases, molecular diagnostics, point-of-care testing

Symbol: TLIS

Recent Price: $1.72

Industry: Medical - Devices

CEO: Mr. Robert Kelley MBA

Sector: Healthcare

Employees: 99

Address: 230 Constitution Drive, Menlo Park, CA 94025

Phone: 650 433 3000

Last updated: 2024-12-31

Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

TPST-1495, TPST-1120, TREX-1

Tempest Therapeutics Inc. is a clinical-stage oncology company developing small molecule therapeutics to treat cancer, with key programs in TPST-1495 and TPST-1120, and research in TREX-1 enzyme modulation.

Tags: biotechnology, cancer treatment, clinical-stage, drug development, immune response, oncology, small molecule therapeutics

Symbol: TPST

Recent Price: $0.84

Industry: Biotechnology

CEO: Mr. Stephen R. Brady J.D., LLM

Sector: Healthcare

Employees: 17

Address: 7000 Shoreline Court, South San Francisco, CA 94080

Phone: 415 798 8589

Last updated: 2024-12-31

Turnstone Biologics Corp.

Turnstone Biologics Corp. logo
Market Cap: Lowest
Employees: Low

TIDAL-01

Turnstone Biologics Corp. is a clinical stage biotechnology company focused on developing medicines for treating and curing patients with solid tumors. Its lead product, TIDAL-01, is in Phase 1 clinical trials for various cancers.

Tags: TILs, biotechnology, clinical stage, immunotherapy, solid tumors

Symbol: TSBX

Recent Price: $0.50

Industry: Biotechnology

CEO: Dr. Sammy J. Farah M.B.A., Ph.D.

Sector: Healthcare

Employees: 82

Address: 9310 Athena Circle, LA Jolla, CA 92037

Phone: 347-897-5988

Last updated: 2024-12-31

2seventy bio, Inc.

2seventy bio, Inc. logo
Market Cap: Low
Employees: Low

idecabtagene vicleucel

2seventy bio, Inc. is a cell and gene therapy company focusing on cancer treatment research, development, and commercialization, with products including idecabtagene vicleucel and collaborations with Bristol-Myers Squibb.

Tags: biotechnology, cancer treatment, cell therapy, gene therapy, multiple myeloma

Symbol: TSVT

Recent Price: $2.89

Industry: Biotechnology

CEO: Mr. William D. Baird III, M.B.A.

Sector: Healthcare

Employees: 274

Address: 60 Binney Street, Cambridge, MA 02142

Phone: 339 499 9300

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08

Tango Therapeutics, Inc.

Tango Therapeutics, Inc. logo
Market Cap: Medium
Employees: Low

TNG908

Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.

Tags: BRCA1/2-mutant cancers, Gilead Sciences, STK11-mutant cancers, TNG908, biotechnology, cancer treatment, drug development, methylthioadenosine phosphorylase, protein arginine methyltransferase 5, strategic collaboration, synthetic lethal

Symbol: TNGX

Recent Price: $3.10

Industry: Biotechnology

CEO: Dr. Barbara L. Weber M.D.

Sector: Healthcare

Employees: 140

Address: 100 Binney Street, Cambridge, MA 02142

Phone: 857 320 4900

Last updated: 2024-12-31